Published in Law and Health Weekly, March 15th, 2008
The work will be headed by Dr. Albrecht Mueller of the University of Wuerzburg, Wuerzburg, Germany under a Material Transfer Agreement between International Stem Cell Corporation (ISCO) and the University of Wuerzburg.
"The fact that Dr. Mueller and the University of Wuerzburg have approved ISCO's human parthenogenetic stem cells for research is a strong validation of their value in creating therapeutic cells that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly